Search Results:
CLINICAL TRIAL 19117
A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients with HER-2 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19646
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20030
A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node or T3N0 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20159
A Phase 1 Study of ZW49 in Patients with Locally Advanced (Unresectable) or Metastatic HER2-Expressing Cancers
Disease Site: Esophagus, Breast
View Trial DetailsCLINICAL TRIAL 20349
A Phase 2 Study of TAS-120 in Metastatic Breast Cancers Harboring Fibroblast Growth Factor Receptor (FGFR) Amplifications
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20487
Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease
Disease Site: Brain and Nervous System, Breast, Leptomeningeal (LMD)
View Trial DetailsCLINICAL TRIAL 20631
Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20899
Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Disease Site: Brain and Nervous System, Breast
View Trial DetailsCLINICAL TRIAL 20902
A Phase I Trial of Capecitabine in Combination with Cemiplimab in Patients with Hormone Receptor Positive Metastatic Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20915
A Phase II Study of HER2 directed Dendritic Cell (DC1) vaccine Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients with HER-2 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21199
A Phase 3, Randomized, Double-Blind Study of Trilaciclib or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE 2)
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21378
Phase 1 Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab / Trastuzumab in Patients with Metastatic HER2-Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20479
Efficacy of SOAR (Survivors Overcoming and Achieving Resiliency) Survivorship Workshop for Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 16933
Older Breast Cancer Patients: Risk For Cognitive Decline
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21448
Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21610
The Influence of Psychosocial Factors on Opioid Decision-Making among Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19000
Evaluation of Anti-Her2 and Anti-Her3 T-Helper Response in Primary Breast Cancer
Disease Site: Breast - Female
View Trial DetailsCLINICAL TRIAL 21164
Radiomics and Pathomics to Predict Upstaging of DCIS
Disease Site: Breast
View Trial Details
